wide
believ
host
prion
protein
prp
without
nucleic
acid
convert
infecti
form
prpre
caus
transmiss
encephalopathi
tse
human
sporad
cjd
scjd
endem
sheep
scrapi
epidem
bse
mani
detail
investig
prp
proteom
studi
protein
verifi
infecti
tse
particl
pursu
even
though
brain
homogen
without
prp
retain
complet
infecti
titer
defin
protein
may
integr
process
protect
agent
genom
develop
streamlin
highyield
purif
infecti
fucjd
mous
brain
particl
minim
prp
proteinas
k
pk
abolish
residu
particl
prp
reduc
infect
virals
particl
lack
prp
vs
without
pk
furthermor
nonprp
protein
still
present
posit
identifi
high
titer
fucjd
particl
without
detect
prp
mass
spectrometri
lcmsm
peptid
link
viral
motif
environmentalvir
databas
evid
parallel
uninfect
control
host
compon
also
identifi
pk
nonpk
treat
particl
fucjd
mous
brain
human
scjd
brain
abund
cellular
data
sever
surpris
includ
find
huntingtin
scjd
normal
human
brain
sampl
similarli
neural
wiskottaldrich
sequenc
multivesicular
endosom
compon
associ
retrom
app
alzheim
amyloid
process
scjd
cellular
find
suggest
new
therapi
direct
retromervesicular
traffick
neurodegen
diseas
may
also
counteract
lateonset
scjd
prp
amyloid
patholog
cell
type
speciesspecif
manuelidi
et
al
iv
agent
replic
latenc
featur
inexplic
prion
convers
model
miyazawa
et
al
v
fundament
viral
characterist
infecti
particl
includ
nm
size
manuelidi
manuelidi
et
al
addit
prpre
fail
correl
infecti
titer
fulfil
koch
postul
manuelidi
gonzalez
et
al
two
highli
public
report
claim
recombin
prp
rprp
convert
infecti
form
vitro
legnam
et
al
wang
et
al
critic
data
exclud
nonprp
protein
addit
nucleic
acid
infecti
agent
howev
rprp
find
never
reproduc
other
use
independ
materi
manuelidi
laboratori
contamin
remain
acknowledg
problem
vitro
prp
prpre
convers
cosseddu
et
al
inde
numer
attempt
make
rprp
infecti
past
year
fail
yield
infect
unfortun
one
group
publish
neg
result
timm
et
al
final
live
cell
prpre
increas
enorm
high
level
infect
reduc
log
miyazawa
et
al
demonstr
prp
part
defens
host
respons
elimin
infecti
agent
build
host
prion
prpre
amyloid
becom
runaway
defens
mechan
infect
agent
critic
pk
destroy
virtual
prp
brain
homogen
without
reduc
infecti
titer
miyazawa
et
al
experi
pk
digest
form
prp
includ
pk
sensit
prp
prpsen
recent
propos
real
infecti
form
cronier
et
al
colbi
prusin
mani
nonprp
protein
visual
highli
infecti
complex
brain
homogen
prp
destroy
becam
critic
isol
character
smaller
subset
residu
protein
strongli
bind
associ
infecti
agent
one
protein
especi
purifi
agent
prepar
protect
agent
strainspecif
genom
particip
pathogenesi
better
purifi
infect
first
establish
reproduc
rapid
cultur
system
quantit
agent
titrat
repres
cjd
scrapi
strain
vitro
assay
verifi
anim
assay
nishida
et
al
liu
et
al
miyazawa
et
al
miyazawa
et
al
develop
new
streamlin
procedur
quantit
recov
fucjd
agent
infect
brain
homogen
contrast
quantit
recoveri
start
titer
recov
purif
molecularli
complex
prpre
aggreg
nuclei
abund
brain
lipid
remov
without
deterg
enzym
sucros
step
gradient
retriev
start
brain
infect
reduc
prp
also
minim
cell
protein
pk
digest
simplifi
particl
demonstr
high
particl
infect
preserv
even
prp
undetect
sum
nonprp
protein
critic
agent
integr
infect
form
detect
prp
although
protein
purifi
tse
particl
visual
blot
nucleic
acid
bind
protein
sensit
broad
sequencespecif
analys
need
lcmsm
combin
sophist
comput
comparison
parallel
uninfect
infect
brain
advantag
character
particl
peptid
lcmsm
power
techniqu
extraordinari
sensit
orient
toward
separ
gener
detect
identif
molecul
resolv
mass
ioniz
fenn
et
al
use
lcmsm
swath
compar
particl
normal
fucjd
infect
brain
also
compar
control
scjd
infect
human
brain
particl
prepar
detail
mani
virallink
protein
remain
highli
infecti
fucjd
particl
prepar
detect
prp
lcmsm
robust
result
compat
belief
prp
major
even
essenti
structur
element
infecti
particl
purif
analyt
approach
shown
use
resolv
tse
molecular
compon
fundament
infect
two
gram
frozen
infect
control
uninfect
brain
contain
cell
equival
ce
homogen
stroke
smooth
glass
b
type
pestl
volum
tb
mm
triscl
ph
mm
pmsf
mgml
dapi
remov
collagen
larg
debri
homogen
filter
steriflip
vacuumdriven
system
millipor
corp
bellierica
ca
filter
wash
tb
yield
ceml
start
refer
aliquot
filter
homogen
frozen
analyt
infect
titrat
separ
nuclei
cytosol
myelinmembran
facilit
adjust
filtrat
sucros
follow
centrifug
min
beckman
rotor
small
nuclear
pellet
strongli
dapi
posit
dna
thick
float
white
membranelipid
fraction
show
weak
dapi
fluoresc
nonfluoresc
cytosol
collect
syring
adjust
sucros
tb
centrifug
min
clear
residu
membran
nuclear
contamin
yield
highli
infecti
k
supernat
releas
start
fucjd
brain
infect
cytosol
achiev
without
deterg
make
possibl
studi
effect
later
ad
deterg
enzym
triton
final
concentr
rnase
done
method
use
make
particl
control
scjd
cerebr
cortex
latter
male
typic
clinic
patholog
scjd
posit
prpre
western
blot
digest
mgml
rnase
calbiochem
min
infecti
particl
rapidli
concentr
pellet
min
microfug
use
pool
k
pellet
suspend
bath
sonic
mm
triscl
ph
enabl
increas
load
sucros
step
gradient
purif
briefli
ceml
load
gradient
spun
tla
rotor
h
reduc
centrifug
time
h
vs
h
previous
use
better
assess
chang
sediment
rnase
proteinas
k
pk
pk
digest
detail
result
section
done
prior
gradient
load
stop
pmsf
miyazawa
et
al
gradient
ml
sampl
sucros
layer
ml
ml
ml
sucros
benzonas
bz
sigma
test
uml
h
reaction
supplement
mm
mgcl
bz
termin
mm
edta
ph
infecti
titer
determin
neuron
cell
assay
dilut
miyazawa
et
al
b
determin
tissu
cultur
infecti
dose
tcid
bioassay
threefold
less
sensit
prolong
endpoint
mous
ld
bioassay
reliabl
varieti
mouseadapt
tse
agent
strain
includ
human
kuru
agent
l
rml
scrapi
strain
miyazawa
et
al
fucjd
infect
mous
brain
typic
contain
tcid
per
cell
equival
tcid
per
gram
brain
cell
titer
done
fraction
multipl
independ
experi
averag
tabl
molecular
compon
western
blot
specif
protein
prp
tubulin
colloid
gold
stain
protein
done
previous
manuelidi
et
al
extract
nucleic
acid
assay
nanodrop
reader
sybr
gold
stain
agaros
gel
load
cell
equival
ce
purifi
nucleic
acid
manuelidi
pg
per
band
easili
detect
lane
dilut
marker
reflect
sensit
six
order
magnitud
start
cell
dna
mg
per
cell
concentr
mous
human
brain
fraction
contain
mg
protein
solubil
fresh
nh
hco
mm
dtt
min
quench
iodoacetamid
mm
dilut
urea
prior
digest
mg
ly
c
h
follow
sequenti
sequenc
grade
trypsin
promega
digest
h
mg
overnight
mg
h
pk
sampl
ce
treat
except
trypsin
reduc
markedli
reduc
protein
content
see
result
section
sampl
desalt
run
lcmsm
swath
parallel
pair
member
yale
keck
facil
describ
supplement
inform
first
develop
procedur
better
purifi
expos
infecti
brain
particl
test
inher
sensit
enzymat
digest
varieti
heterogen
uncharacter
compon
previou
infecti
brain
fraction
well
tse
agent
trap
prp
amyloid
compromis
digest
close
quantit
yield
start
brain
infect
along
increas
agent
puriti
achiev
wherea
previou
disaggreg
approach
yield
start
homogen
titer
manuelidi
et
al
new
streamlin
procedur
detail
brain
fucjd
particl
repres
fig
use
success
tse
strainsspeci
model
compar
subcellular
characterist
obtain
k
hamster
scrapi
brain
although
human
brain
scjd
titer
accur
evalu
human
inocul
overal
protein
prp
reduct
human
scjd
follow
pattern
found
fucjd
henc
purifi
human
scjd
particl
also
compar
uninfect
control
proteom
analys
titrat
fucjd
agent
show
enhanc
separ
tse
agent
particl
brain
cellular
complex
high
lipid
content
secondari
neurodegen
patholog
tabl
moreov
agent
isol
contrast
standard
sarkosyl
procedur
purifi
prp
amyloid
aggreg
yield
start
titer
hilmert
diring
weber
et
al
nuclear
contamin
poor
separ
agent
myelin
lipidrich
membran
patholog
debri
blood
vessel
collagen
compromis
previou
agent
purif
found
filtrat
homogen
remov
virtual
blood
vessel
collagen
loss
start
titer
addit
sucros
stabil
nuclei
improv
separ
low
speed
pellet
high
sucros
concentr
also
separ
major
float
lipidrich
membran
time
remov
start
prp
prpre
omiss
deterg
imperm
micel
enhanc
separ
start
brain
infect
cytosol
without
artifactu
aggreg
fig
tabl
also
discov
rnase
treatment
facilit
concentr
essenti
infecti
particl
simpl
min
centrifug
moreov
purifi
particl
contain
rel
low
protein
nucleic
acid
featur
necessari
detect
agentspecif
molecul
method
outlin
fig
straightforward
take
day
rapid
sucros
step
gradient
purifi
infecti
particl
residu
protein
requir
infect
figur
show
typic
western
blot
prp
sequenti
subcellular
fucjd
brain
fraction
cytosol
contain
sequenti
purif
fucjd
infecti
brain
particl
total
start
homogen
major
compon
subcellular
fraction
averag
six
independ
experi
shown
infecti
titer
vari
less
threefold
among
experi
recoveri
base
replic
tcid
determin
neuron
cell
sequenti
cell
passag
previous
fucjd
miyazawa
et
al
see
fig
individu
prepar
typic
show
tcidgram
brain
cell
data
summar
independ
infect
titrat
averag
prpprpre
protein
nucleic
acid
prepar
start
brain
prp
includ
abnorm
prpre
lane
purifi
kg
spin
min
pellet
residu
membran
nuclei
lane
littl
loss
agent
addit
prp
remov
k
supernat
contain
remain
total
prp
lane
benzonas
bz
digest
nucleic
acid
reduc
prp
content
shown
purifi
particl
bz
lane
compar
undigest
control
lane
thu
bz
reduc
infecti
titer
accord
prion
proteinonli
hypothesi
stark
contrast
digest
particl
mg
pk
h
show
visibl
prp
lane
even
though
lane
contain
higher
load
lane
principl
pk
digest
prionless
sampl
lose
log
infect
accord
loss
start
total
prp
infecti
titer
reduc
see
fig
background
subtract
prp
valu
reflect
residu
kda
pk
band
bind
prp
antibodi
exampl
h
digest
high
pk
mgml
fig
lane
show
kda
pk
band
arrowhead
protein
subsequ
stain
gold
blot
fig
also
markedli
reduc
lane
compar
undigest
lane
ad
pk
kda
domin
band
although
prp
bare
detect
h
pk
digest
mani
goldstain
protein
kda
clearli
surviv
pk
digest
larg
amount
rnase
ad
pk
stop
fig
lane
band
kda
remov
concentr
particl
data
encourag
purif
rapid
concentr
fucjd
infecti
particl
brain
diagram
new
streamlin
procedur
major
infecti
fraction
fx
brain
cytosol
spun
yield
highli
infecti
supernat
reduc
lysosom
mitochondria
patholog
debri
pellet
concentr
infecti
particl
reduc
solubl
protein
also
allow
increas
load
sucros
step
gradient
purif
b
western
blot
show
typic
fucjd
brain
prp
total
prp
sequenti
fraction
indic
lane
note
contain
larg
amount
prp
littl
infect
tabl
addit
enzym
bz
pk
indic
lane
well
rel
load
fraction
note
load
lane
pk
mgml
h
show
visibl
prp
start
prp
detect
chemifluoresc
contrast
benzonas
uml
effect
prp
compar
lane
marker
kda
indic
c
western
blot
show
prp
crude
cytosol
lane
pk
digest
mgml
h
lane
h
lane
h
indic
addit
sampl
lane
treat
rnase
prior
pk
h
digest
rnase
lane
less
visibl
prpre
band
dot
littl
prpre
seen
h
digest
control
lane
load
uninfect
brain
lane
n
show
pk
band
arrowhead
bind
prp
antibodi
nonspecif
without
background
subtract
h
digest
littl
start
prp
sampl
lane
mark
assay
infect
see
fig
gold
stain
blot
c
show
promin
residu
protein
band
pk
intens
pk
band
kda
arrowhead
smaller
rnase
band
kda
lane
rnase
effect
remov
centrifug
evalu
agent
particl
sequenti
purifi
fraction
high
infect
tabl
also
summar
infect
determin
establish
dilut
titrat
see
method
along
sequenti
stepwis
reduct
total
protein
prp
nucleic
acid
result
highli
reproduc
repres
averag
six
independ
brain
prepar
determin
tissu
cultur
infecti
dose
tcid
per
sampl
fraction
noninfecti
protein
lipid
visibl
reduc
sucros
gradient
sediment
low
final
amount
form
prp
gradient
sediment
prpre
also
report
subcellular
fraction
presum
infecti
form
prpre
repres
total
fucjd
brain
prp
factor
prpre
subcellular
fraction
reduc
parallel
total
prp
quantit
recoveri
infect
routin
obtain
sediment
gradient
particl
contrast
vast
major
prp
prpre
remov
without
deterg
protein
also
reduc
nucleic
acid
substanti
remov
indic
minim
artifact
induc
prepar
procedur
whole
brain
homogen
use
previous
test
pk
induc
prp
loss
infecti
brain
titer
miyazawa
et
al
refer
maxim
prpre
band
visual
limit
pk
mg
ml
min
although
previous
form
prp
whole
brain
homogen
reduc
invis
level
extrem
pk
digest
mg
h
without
loss
titer
mani
homogen
protein
surviv
similarli
shown
less
complex
cytosol
fig
prp
reduc
thu
purifi
subcellular
infecti
fraction
pursu
minim
set
protein
critic
agent
structur
resist
progress
purif
less
obviou
patholog
host
compon
adher
tightli
infecti
particl
also
reveal
wherea
aggreg
prp
trap
infecti
agent
also
entangl
brain
protein
includ
ubiquitin
apolipoprotein
j
manuelidi
et
al
may
retain
increas
agent
purif
especi
pk
digest
seri
infect
titrat
differ
subcellular
fraction
show
pk
abrog
prp
prpre
reduc
infect
figur
graph
tcid
complex
purifi
agent
prepar
without
differ
addit
note
beneath
bar
set
experi
bar
cluster
show
independ
brain
prepar
nonpk
parallel
fraction
darker
bar
cluster
cluster
cytosol
treat
high
level
pk
mgml
h
indic
bar
western
blot
aliquot
titer
shown
figur
untreat
control
lane
four
digest
sampl
assay
infect
lane
mark
asterisk
prp
start
homogen
sampl
also
indic
beneath
bar
reduct
prp
reduc
infect
rnase
also
effect
titer
moreov
purifi
treat
mgml
h
b
cluster
result
even
less
retain
prp
total
despit
log
reduct
prp
infecti
titer
complet
preserv
without
loss
comparison
ureatrypsin
treatment
swath
analysi
alter
prp
level
instead
reduc
start
titer
log
avoid
artifactu
prp
aggreg
trap
agent
induc
high
g
pellet
use
separ
particl
sucros
gradient
three
sucros
step
gradient
compar
parallel
first
aliquot
contain
triton
second
addit
treat
rnase
third
digest
pk
mgml
h
load
gradient
prp
gold
stain
blot
pk
digest
sampl
shown
figur
lane
pk
visibl
prp
signal
compar
undigest
aliquot
lane
even
though
crude
show
loss
titer
either
h
pk
high
concentr
sem
indic
n
gel
blot
assay
sampl
shown
figur
b
digest
h
pk
rnase
show
low
prp
meaning
valu
distinguish
background
miyazawa
et
al
regardless
infect
remain
high
indistinguish
parallel
control
appreci
prp
shown
fig
c
total
infect
recov
sucros
step
gradient
treat
mgml
h
load
gradient
note
high
tcid
found
recov
control
rnase
pk
gradient
even
though
prp
could
detect
mean
bar
differ
gradient
step
pk
sampl
shown
figur
strong
posit
tcid
shown
figur
brain
fraction
treat
high
bz
concentr
indic
show
signific
log
loss
titer
contrast
prpless
pk
sampl
triton
tx
alter
agent
titer
pk
lane
higher
load
furthermor
even
load
lane
contain
concentr
ce
individu
sucros
fraction
collect
lane
still
show
detect
prp
despit
lack
detect
prp
visibl
gold
stain
protein
remain
addit
strong
pk
band
gradient
fraction
infect
assay
show
two
remark
featur
pk
digest
sucros
gradient
fraction
first
infect
recov
gradient
second
shift
sediment
infecti
agent
indic
infecti
particl
smaller
valu
appar
size
control
particl
figur
compar
tcid
assay
pk
treat
blot
rnase
control
blot
b
gradient
fraction
strong
prpre
respons
indic
cell
earli
postinfect
low
ce
indic
high
titer
miyazawa
et
al
b
sucros
fraction
without
prp
induc
vigor
prpre
respons
cell
lane
recov
infect
sucros
fraction
blot
b
rnase
gradient
total
tcid
recov
infecti
particl
rapidli
pass
sucros
step
concentr
bottom
sucros
step
control
uninfect
brain
ncn
lane
fig
earli
passag
appear
infect
sucros
gradient
step
pk
treat
shown
fig
b
rnase
treatment
ident
ce
gradient
sampl
inocul
duplic
well
indic
cell
well
undigest
treat
limit
pk
prpre
shown
total
tcid
recov
gradient
fig
strikingli
gradient
sampl
without
prp
highli
infecti
pk
pretreat
also
reduc
appar
size
infecti
particl
infect
prionless
sampl
migrat
sucros
step
contrast
panel
b
show
tcid
concentr
bottom
small
cushion
sucros
step
accord
previou
undigest
particl
studi
gradient
recoveri
slightli
higher
arrowhead
point
fucjd
specif
band
found
cell
brain
manuelidi
et
al
prpre
fold
chang
cell
alter
agent
intrins
characterist
determin
reinocul
mice
arjona
et
al
standard
curv
tcid
assay
determin
serial
dilut
miyazawa
et
al
endpoint
titer
dilut
ce
induc
prpre
respons
indic
cell
control
normal
brain
sampl
n
cn
lane
b
show
prpre
provok
uninfect
homogen
fig
blot
sampl
gradient
analysi
collect
sucros
step
top
show
prp
bottom
show
subsequ
colloid
gold
stain
protein
pk
total
cell
prp
indic
lane
pk
prior
load
gradient
prp
recov
sucros
step
top
even
high
ce
load
ce
lane
protein
howev
still
visibl
gold
stain
bottom
addit
heavi
kda
pk
band
blot
b
contrast
fucjd
sampl
induc
prpre
assay
total
infect
recov
three
gradient
indistinguish
quantit
graph
figur
result
indic
smaller
tse
particl
size
previous
determin
one
still
keep
ultrastructur
nm
diamet
dens
particl
observ
infect
cell
interestingli
bz
digest
nucleic
acid
greater
effect
titer
pk
figur
show
bz
two
differ
concentr
reduc
titer
log
past
nucleas
treatment
aggreg
pellet
materi
caus
loss
infect
manuelidi
nucleas
sensit
purifi
agent
particl
deserv
investig
sum
current
result
show
protein
prp
essenti
tse
agent
infect
prp
singular
focu
tse
work
last
year
data
combin
previou
sucros
gradient
separ
infecti
particl
motiv
closer
look
minor
set
protein
remain
purifi
agent
prepar
detect
sever
protein
subtyp
particl
nucleic
acid
bind
protein
manuelidi
includ
affin
biotinyl
recombin
sphinx
dna
sequenc
also
detect
protein
band
bind
antibodi
sphinx
orf
data
shown
howev
total
protein
especi
pk
treat
particl
low
protein
level
advantag
use
sensit
inclus
approach
analysi
wherea
high
titer
fucjd
particl
use
ms
reduc
pk
lost
log
infect
ureatrypsin
treatment
even
without
ly
c
prior
ms
analysi
obviat
ms
biohazard
risk
expect
western
blot
ms
control
infect
sampl
subject
pk
show
mani
protein
includ
prp
fucjd
contain
prp
p
uninfect
control
consist
preferenti
sediment
prpre
aggreg
present
control
sampl
howev
pk
neither
sampl
detect
prp
ms
possibl
margin
kda
band
detect
overload
western
blot
fucjd
sampl
start
prp
reflect
peptid
cross
react
antiprp
polyclon
antibodi
inde
sever
cellular
viral
peptidas
proteas
clearli
present
pk
addit
kda
virallink
protein
tabl
ii
pk
sequenc
use
digest
also
detect
solidifi
uniqu
origin
proteas
found
infect
sampl
pk
treat
particl
prove
inform
analyz
sequenc
could
clearli
identifi
fucjd
parallel
uninfect
control
absenc
normal
mean
present
preferenti
bound
infecti
particl
rather
cosedi
cellular
protein
pk
treatment
also
allow
discoveri
molecul
insuffici
repres
complex
undigest
sampl
numer
cellular
protein
quantit
differenti
swath
detail
separ
tabl
ii
list
sequenc
highest
ident
viral
score
detect
parallel
uninfect
control
remain
signific
peptid
score
list
supplement
first
notabl
mani
differ
rna
dna
viral
group
repres
includ
retrovirus
hiv
coronavirus
herpesvirus
goat
frog
origin
plant
virus
pepper
leaf
grapevin
insect
bacteri
virus
none
virus
ever
lab
unlik
contamin
infect
control
sampl
without
sequenc
alway
prepar
parallel
ident
reagent
secondli
fair
number
sequenc
ncbi
viral
databas
identifi
limit
geograph
locat
unlik
environ
antarct
lake
china
hungari
brazil
australian
seawat
thirdli
signific
viral
ident
limit
protein
class
notabl
env
glycoprotein
viral
replic
polymeras
protein
capsid
nucleic
acid
bind
protein
togeth
forego
suggest
sequenc
motif
may
function
sever
dispar
viral
class
peptid
would
never
identifi
high
background
sampl
brought
pk
treatment
markedli
reduc
protein
requir
infect
among
replicas
peptid
also
notabl
bacteri
rep
protein
confirm
dna
sequenc
particl
rep
nucleic
acid
manuelidi
although
sequenc
list
may
integr
agent
compon
well
other
may
discov
enrich
particl
prepar
deserv
studi
determin
potenti
role
infect
particl
process
human
scjd
could
accur
titer
pk
use
purifi
human
scjd
particl
howev
polyprotein
divers
virus
onion
mammal
identifi
nonpk
scjd
detect
control
human
brain
view
higher
protein
background
nonpk
treat
sampl
sequenc
may
signifi
particl
process
patholog
product
rather
integr
agent
molecul
hand
human
gene
identifi
scjd
control
human
began
give
strong
indic
relev
patholog
neuron
repair
sequenc
particl
associ
high
ident
list
unexpectedli
neural
wiskottaldridch
protein
huntintin
addit
expect
cell
protein
includ
vesicl
endosom
multivesicular
chaperon
protein
like
involv
agent
traffick
process
also
obviou
expect
mitochondri
protein
also
identifi
consist
cosedi
mitochondri
dna
detect
pcr
everi
infecti
prepar
date
includ
treat
nucleas
manuelidi
extens
cellular
gene
identifi
relev
tse
model
detail
separ
exclus
focu
prp
domin
belief
prpre
misfold
host
protein
without
nucleic
acid
causal
infecti
tse
agent
obscur
unresolv
natur
real
infecti
particl
infecti
prepar
test
sensit
molecular
method
contain
appreci
nucleic
acid
viral
size
kb
well
protein
manuelidi
awar
assess
detail
character
other
nonprp
protein
purifi
tse
agent
prepar
disrupt
nucleic
acidprotein
complex
destroy
infect
manuelidi
et
al
manuelidi
contrast
reproduc
quantit
recoveri
highli
infecti
tse
particl
without
detect
prp
clear
mark
reduct
prp
background
protein
pk
digest
led
substanti
proteom
data
demonstr
nonprp
protein
strongli
bind
essenti
tse
agent
infect
one
viral
cellular
protein
could
protect
strainspecif
genom
rapid
purif
method
detail
reason
univers
effect
fucjd
l
scrapi
agent
thu
effect
model
includ
high
titer
k
scrapi
scjd
agent
infect
hamster
brain
moreov
streamlin
procedur
isol
fucjd
brain
particl
contain
log
infect
found
test
tube
prpre
convers
assay
done
varieti
condit
castilla
et
al
cosseddu
et
al
klingeborn
et
al
thu
current
pk
treat
infecti
particl
highyield
sourc
imparti
identifi
critic
nonprp
agent
compon
approach
open
window
discoveri
take
work
defin
integr
agent
sequenc
includ
viral
nucleic
acid
protect
capsid
protein
although
state
viral
particl
tse
prusin
viruslik
array
electron
dens
nm
particl
identifi
cytoplasm
infect
normal
cell
clearli
separ
abund
intracellular
prp
amyloid
fiber
ultrastructur
particl
compar
biochem
isol
infecti
particl
nm
separ
abnorm
prp
fibril
silveira
et
al
manuelidi
abil
virus
induc
misfold
host
protein
patholog
fibrillar
aggreg
increasingli
realiz
detail
molecular
level
hou
et
al
manuelidi
present
studi
consist
prp
chang
part
host
innat
defens
mechan
inde
prp
misfold
becom
runaway
patholog
respons
infect
environment
tse
agent
miyazawa
et
al
addit
stress
induc
protein
aggreg
bacteri
biofilm
alzheim
amyloid
neurofibrillari
tangl
neurodegen
diseas
accumul
abnorm
protein
fibril
promin
underscor
patholog
uniti
manuelidi
other
may
wish
pursu
invis
prp
infecti
pk
treat
brain
sampl
studi
abund
virallink
protein
highest
score
viral
link
peptid
pk
treat
fucjd
detect
uninfect
supplement
show
rest
signific
peptid
probabilitybas
protein
identif
done
describ
perkin
et
al
shifman
et
al
associ
tse
infecti
particl
would
seem
fruit
virallink
peptid
sequenc
enumer
use
immedi
synthes
correspond
cdna
oligonucleotid
identifi
agent
probe
posit
differ
tse
model
common
strainspecif
molecul
also
defin
test
cdna
probe
differ
human
agent
alreadi
propag
rang
speci
cell
type
manuelidi
current
proteom
analys
also
identifi
numer
cellular
protein
like
import
new
diagnost
therapeut
approach
although
quantit
compar
swath
data
control
infect
sampl
report
separ
howev
alreadi
clear
cellular
gene
present
drive
discoveri
new
host
target
delay
agentinduc
neurodegener
aggreg
amyloid
format
surpris
find
sever
protein
associ
human
scjd
particl
normal
control
brain
includ
wiskottaldridch
protein
well
expect
vacuolarendosom
vesicular
traffick
retrom
protein
particular
set
protein
csf
may
abl
diagnost
distinguish
differ
type
dementia
earli
clinic
stage
sever
peptid
also
specifi
new
pathway
target
therapeut
result
suggest
pharmacolog
chaperon
direct
retrom
current
investig
delay
alzheim
diseas
mecozzi
et
al
may
also
retard
accumul
prp
amyloid
associ
neurodegen
chang
tse
